Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 12,390
+280 (2.31%)
Nov 2, 2026, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 562.6 billion as of October 30, 2026. It is the 15,612th most valuable company in the world and the 420th biggest in South Korea. Its market cap has decreased by 26.15% in one year.
Market Cap
562.60B
Enterprise Value
500.26B
Revenue
82.17B
Global Rank
Country Rank
#420 South Korea
PE Ratio
23.44
ChartMarket Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 562.60B, an increase of 201.00%. That is a compound annual growth rate of 80.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 562.60B | -35.32% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Komipharm International | 651.95B |
| Chabiotech | 624.39B |
| Proteina | 599.21B |
| Pharmicell | 564.04B |
| Hyundai Bioscience | 518.22B |
| GI Innovation | 434.19B |
| GC Corp. | 415.33B |
| Medy-Tox | 412.68B |